Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 443

1.

Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.

Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM.

Ann Surg Oncol. 2009 Oct;16(10):2697-704. doi: 10.1245/s10434-009-0641-z.

PMID:
19653045
2.

Contralateral prophylactic mastectomy in an Asian population: a single institution review.

Sim Y, Tan VK, Ho GH, Wong CY, Madhukumar P, Tan BK, Yong WS, Ng YY, Ong KW.

Breast. 2014 Feb;23(1):56-62. doi: 10.1016/j.breast.2013.10.008.

PMID:
24275318
3.

Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.

Damle S, Teal CB, Lenert JJ, Marshall EC, Pan Q, McSwain AP.

Ann Surg Oncol. 2011 May;18(5):1356-63. doi: 10.1245/s10434-010-1434-0.

PMID:
21125335
4.

Perceptions of contralateral breast cancer: an overestimation of risk.

Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T.

Ann Surg Oncol. 2011 Oct;18(11):3129-36. doi: 10.1245/s10434-011-1914-x.

PMID:
21947590
5.

Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.

Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A.

Ann Surg Oncol. 2012 Aug;19(8):2600-6. doi: 10.1245/s10434-012-2299-1.

PMID:
22396004
6.

Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.

Yao K, Stewart AK, Winchester DJ, Winchester DP.

Ann Surg Oncol. 2010 Oct;17(10):2554-62. doi: 10.1245/s10434-010-1091-3.

PMID:
20461470
7.

Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.

Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA.

J Clin Oncol. 2009 Mar 20;27(9):1362-7. doi: 10.1200/JCO.2008.20.1681.

PMID:
19224844
8.

Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer.

Stucky CC, Gray RJ, Wasif N, Dueck AC, Pockaj BA.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:330-7. doi: 10.1245/s10434-010-1259-x.

PMID:
20853055
9.

Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.

McGuire KP, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, Shamehdi C, Davis M, Ramos D, Cox CE.

Ann Surg Oncol. 2009 Oct;16(10):2682-90. doi: 10.1245/s10434-009-0635-x.

PMID:
19653046
10.

Issues of regret in women with contralateral prophylactic mastectomies.

Montgomery LL, Tran KN, Heelan MC, Van Zee KJ, Massie MJ, Payne DK, Borgen PI.

Ann Surg Oncol. 1999 Sep;6(6):546-52.

PMID:
10493622
11.

The influence of preoperative MRI on breast cancer treatment.

Miller BT, Abbott AM, Tuttle TM.

Ann Surg Oncol. 2012 Feb;19(2):536-40. doi: 10.1245/s10434-011-1932-8.

PMID:
21751044
12.

Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.

Ashfaq A, McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP, McLaughlin SA, Casey WJ 3rd, Rebecca AM, Kreymerman P, Wasif N.

Ann Surg Oncol. 2014 Sep;21(9):2934-40. doi: 10.1245/s10434-014-3712-8.

PMID:
24756811
13.

Contralateral prophylactic mastectomy.

Rai SS, Mahabir RC, Roberts JW, Song J, Hamid KS, White RR 4th.

Ann Plast Surg. 2011 Sep;67(3):215-9. doi: 10.1097/SAP.0b013e3181fabc4c.

PMID:
21508813
14.

Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.

Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM.

Ann Surg Oncol. 2009 Oct;16(10):2691-6. doi: 10.1245/s10434-009-0547-9.

PMID:
19506956
15.

Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.

Barry PN, Johnson RR, Harkenrider MM, Freeman AB, Kruse B, Wilson MR, Pan J, Dragun AE.

Am J Med Sci. 2012 Dec;344(6):452-6. doi: 10.1097/MAJ.0b013e31824a82ce.

PMID:
22395715
16.

Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.

Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K.

Ann Surg Oncol. 2014 Oct;21(10):3231-9. doi: 10.1245/s10434-014-3956-3.

PMID:
25081341
17.

Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.

King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M.

J Clin Oncol. 2011 Jun 1;29(16):2158-64. doi: 10.1200/JCO.2010.29.4041.

PMID:
21464413
18.

Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.

Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC.

Surgery. 2016 Apr;159(4):1199-209. doi: 10.1016/j.surg.2015.11.001.

PMID:
26704783
19.

Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.

Voguet L, Hébert T, Levêque J, Acker O, Mesbah H, Marret H, Porée P, Body G.

Breast. 2009 Aug;18(4):233-7. doi: 10.1016/j.breast.2009.06.002.

PMID:
19628389
20.

Contralateral prophylactic mastectomy. Predictors of significant histologic findings.

Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F.

Cancer. 2004 Nov 1;101(9):1977-86.

Items per page

Supplemental Content

Support Center